Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions

Immunotherapeutic approaches, including adoptive cell therapy, revolutionized treatment in multiple myeloma (MM). As dendritic cells (DCs) are professional antigen-presenting cells and key initiators of tumor-specific immune responses, DC-based immunotherapy represents an attractive therapeutic appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Verheye, Emma, Bravo Melgar, Jesús, Deschoemaeker, Sofie, Raes, Geert, Maes, Anke, De Bruyne, Elke, Menu, Eline, Vanderkerken, Karin, Laoui, Damya, De Veirman, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778019/
https://www.ncbi.nlm.nih.gov/pubmed/35055096
http://dx.doi.org/10.3390/ijms23020904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778019/
https://www.ncbi.nlm.nih.gov/pubmed/35055096
http://dx.doi.org/10.3390/ijms23020904

Ejemplares similares